Integrity / innovation / cooperation / sharing / wiπn-win

Products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor deve×loped by Merck. In October 2006, Sitagliptin phosphate Januvia was approved• by FDA as the first DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus. The cha‍racteristics of this drug are that it can stimulate insulinδ secretion while reducing hunger without causing weight gain. Hypoglycemi₽a and edema will not occur, and it is suitable for diabetic patie nts with poor blood glucose control and frequent hy✔poglycemia.

View details

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-orient♣ed and realizes industrial development through R&D innovation and technology transfor←mation.

View details

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important products for →the treatment of arthritis. It is well tolerated and has a low i♠ncidence of side effects

View details

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor antagonist↕s. In clinical application, it has good therapeutic effect on atopic a∞sthma and other types of bronchial asthma, and the market prospect is huge. In theσ major category of asthma drugs, leukotriene receptor antagonists €have the fastest growing market share.

View details

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceuticaαl enterprise that is market-oriented and realizes industria÷l development through R&D innovation and technology transformation.

View details

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the ‍second drug approved by FDA for Alzheimer's disease in th≠e United States. Its treatment reaches the target dose and has low toxic and side e☆ffects. It has been widely recognized by our medical community, and good tolerance is its ♠biggest advantage. In October 1999, Donepezil was launched in China under the trade name &qu$ot;Aricept", which is the main chemical drug agains¶t Alzheimer's disease. At present, CFDA has approved a number of dom±estic enterprises to produce donepezil preparations,  the main dosage forms are tablets, capsules, dispersive ✘tablets, oral disintegrating tablets.

View details

Almotriptan

Migraine medication for adolescents

View details

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: A$pixaban (Eliquis, Bristol-Myers Squibb/Pfizer), a direct oral facto'r Xa inhibitor, was approved for use in the 27 EU member  states. The world's first drug approved to prevent venous thromboe♥mbolism (VTE) in adult patients undergoing elective hip or knee replacem ent. From June 2019 to June 2020, the annual sales of apixaban products oveΩrseas reached about $15.4 billion, with a year-on-year growth of nearly 32%, ​and the API consumption reached about 23,960 kg, w≠ith a year-on-year growth of about 28%. Compared with its main competitor, Rivaroxaban,α the drug's annual overseas sales are about $4.5 billion higher.

View details

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is ma&rket-oriented and realizes industrial development through R&D innovation and technolog y transformation.

View details
< 12 > proceed page